Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Myopia and Pediatric Myopia Progression: Market View" report has been added to ResearchAndMarkets.com's offering. This reports provides a data-driven ...

Background/aims Although 0.01% atropine is widely used for myopia control, its efficacy is debated and its effectiveness ...

Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical practice. Brianna Rhue, OD, FAAO, co-founder of West Broward Eyecare, discussed ...

Please provide your email address to receive an email when new articles are posted on . Patients with high myopia experienced the least thinning in retinal nerve fiber layer. The findings could be ...

In a new consensus report, the National Academies of Sciences, Engineering, and Medicine said that myopia should be classified as a disease that requires a medical diagnosis, and that children should ...

Physiologic AL varies materially with age, sex, height, and ethnicity, undermining fixed AL thresholds as broadly applicable risk stratifiers in typical pediatric myopia. Retinal pathology risk ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...